StevenAdesMD

Oncology • Burlington, VT

Professor, Medicine, University of Vermont College of Medicine

Join to view full profile

Dr. Ades is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ades' full profile

Already have an account?

Office
111 Colchester Ave
Hematology/Oncology, Acc Level 2
Burlington, VT 05401
Phone+1 802-847-8400
Is this information wrong?

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
McGill University Faculty of MedicineClass of 1996

Certifications & Licensure

VT State Medical License 2007 - 2024
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01
Completed
Phase 3
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery Start of enrollment: 2006 Feb 01
Completed
Phase 2
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2006 Sep 15
Completed
Phase 2
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Start of enrollment: 2007 May 08
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy Start of enrollment: 2009 Oct 01
Completed
Phase 2
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients Start of enrollment: 2009 Oct 01
Completed
Phase 2
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy Start of enrollment: 2011 Jul 01
Completed
Phase 2
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Start of enrollment: 2012 Jun 12
Active, not recruiting
Phase 2, Phase 3
Phase II Study of Alternating Sunitinib and Temsirolimus Start of enrollment: 2010 Sep 22
Completed
Phase 2
Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) Start of enrollment: 2012 Mar 01
Completed
Phase 2
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer Start of enrollment: 2018 Nov 26
Active, not recruiting
Phase 2, Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers Start of enrollment: 2019 Feb 07
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Improving Rural Clinical Trial Enrollment: Recommendations From the Rural Health Working Group of the Alliance Clinical Trials Network.
Nicole L Stout, Daniel Nikcevich, Tara O Henderson, Preston Steen, Matthias Weiss, Steven Ades, Tammie Mlodozyniec, Amy Koffarnus, Betsy Barnick, Electra D Paskett> ;Journal of Clinical Oncology. 2024 Feb 27
Implementation of a cancer-associated thrombosis prevention program at a rural cancer center.
Heather M Feldman, Eswar Tipirneni, Shamima Khan, Steven Ades, Allison Holm, Chris E Holmes> ;Research and Practice in Thrombosis and Haemostasis. 2024 Jan 1
A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma.
Dylan B Ness, Darcy B Pooler, Steven Ades, Brian J Highhouse, Bridget M Labrie, Jie Zhou, Jiang Gui, Lionel D Lewis, Marc S Ernstoff> ;Cancer Medicine. 2023 Jun 1
1 citations
'CROSS'-ing into the 'Real World': a retrospective cohort study of patients receiving trimodality and bimodality therapy for esophageal cancer.
Luke M Higgins, Nataniel H Lester-Coll, Steven Ades, Maura M Barry, Edward C Borrazzo, Eric K Ganguly, Christopher J Anker> ;Journal of Gastrointestinal Oncology. 2023 Apr 29
1 citations
Evolution of Investigating Informed Assent Discussions about CPR in Seriously Ill Patients.
Renee D Stapleton, Dee W Ford, Katherine R Sterba, Nandita R Nadig, Steven Ades, Anthony L Back, Shannon S Carson, Katharine L Cheung, Janet Ely, Erin K Kross, Robert ...> ;Journal of Pain and Symptom Management. 2022 Jun 1
3 citations
Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER-Medicare analysis.
Steven Ades, Bhargavi Pulluri, Chris E Holmes, Inder Lal, Santosh Kumar, Benjamin Littenberg> ;Cancer Medicine. 2022 Apr 1
1 citations
The Potential for Overtreatment with Total Neoadjuvant Therapy (TNT): Consider One Local Therapy Instead
Christopher J. Anker, Nataniel H. Lester-Coll, Dmitriy Akselrod, Peter A. Cataldo, Steven Ades> ;Clinical Colorectal Cancer. 2021 Nov 18
3 citations
Cancer Care in the Wake of a Cyberattack: How to Prepare and What to Expect.
Steven Ades, Diego Adrianzen Herrera, Timothy Lahey, Alissa A. Thomas, Sakshi Jasra, Maura Barry, Julian Sprague, Kim Dittus, Timothy B Plante, Jamie A. Kelly, Peter A...> ;JCO Oncology Practice. 2021 Aug 2
258 citations
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, ...
Thomas Powles, Tibor Csőszi, Mustafa Ozguroglu, Nobuaki Matsubara, Lajos Géczi, Susanna Y-S Cheng, Yves Fradet, Stéphane Oudard, Christof Vulsteke, Rafael Morales Barr...> ;The Lancet. Oncology. 2021 Jul 1
72 citations
Crizotinib in Patients With MET-Amplified NSCLC
D. Ross Camidge, Gregory A. Otterson, Jeffrey W. Clark, Sai-Hong Ignatius Ou, Jared Weiss, Steven Ades, Geoffrey I. Shapiro, Mark A. Socinski, Danielle Murphy, Umberto...> ;Journal of Thoracic Oncology. 2021 Jun 1
2 citations
Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer.
Nataniel H. Lester-Coll, Steven Ades, James B. Yu, Adam Atherly, H. James Wallace, Brian L. Sprague> ;JAMA Network Open. 2021 Jan 4
8 citations
Nivolumab-Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from Immunotherapy.
Mansour Gergi, Kara K. Landry, Steven Ades, Maura Barry, Neil A. Zakai, Diego Adrianzen Herrera> ;The Oncologist. 2020 Dec 1
24 citations
Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic
Chris E. Holmes, Steven Ades, Susan C. Gilchrist, Daniel Douce, Karen Libby, Britny Rogala, Emily Parenteau, Mary Cushman, Allison Kaigle Holm> ;JCO Oncology Practice. 2020 Apr 8
5 citations
Prospective evaluation of drug-drug interactions in ambulatory cancer patients initiated on prophylactic anticoagulation.
Hank K Ng, Britny Rogala, Steven Ades, Joanna R Schwartz, Takamaru Ashikaga, Pamela M. Vacek, Chris E. Holmes> ;Journal of Oncology Pharmacy Practice. 2020 Feb 11
14 citations
Risk factors for cancer‐associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE‐PACC) study
Daniel R. Douce, Chris E. Holmes, Mary Cushman, Charles D. MacLean, Steven Ades, Neil A. Zakai> ;Journal of Thrombosis and Haemostasis. 2019 Dec 1
6 citations
Nanoparticle‐based targeted cancer strategies for non‐invasive prostate cancer intervention
Nicholas H. Farina, Areg Zingiryan, Michael A. Vrolijk, Scott D. Perrapato, Steven Ades, Gary S. Stein, Jane B. Lian, Christopher C. Landry> ;Journal of Cellular Physiology. 2018 Sep 1
4 citations
Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.
Steven Ades, Daniel R. Douce, Chris E. Holmes, S. Cory, Shannon M. Prior, Saulius Butenas, Peter W. Callas, Mary Cushman> ;Journal of Thrombosis and Haemostasis. 2018 Jun 1
14 citations
NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors
Michelle Yang, Ryan F. Coates, Abiy B. Ambaye, Valerie M. Cortright, Jeannette Mitchell, Alexa M. Buskey, Richard Zubarik, James G. Liu, Steven Ades, Maura M. Barry> ;Biomarker Research. 2018 Apr 18
193 citations
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and ...
Harpreet Wasan, Peter Gibbs, Navesh K Sharma, Julien Taieb, Volker Heinemann, Jens Ricke, Marc Peeters, Michael Findlay, Andrew Weaver, Jamie Mills, Charles Wilson, Ri...> ;The Lancet. Oncology. 2017 Sep 1
6 citations
Effectiveness of aprepitant in addition to ondansetron in the prevention of nausea and vomiting caused by fractionated radiotherapy to the upper abdomen (AVERT)
Steven Ades, Michele Y. Halyard, K. Wilson, Takamaru Ashikaga, R. Heimann, S. Kumar, W. Blackstock> ;Supportive Care in Cancer. 2017 May 1
7 citations
Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study
Masanori Mori, Yongli Ji, Santosh Kumar, Takamaru Ashikaga, Steven Ades> ;International Journal of Clinical Oncology. 2017 Apr 1
18 citations
Randomized phase II study of loratadine for the prevention of bone pain caused by pegfilgrastim
Julia Moukharskaya, D M Abrams, Takamaru Ashikaga, Farrah B. Khan, Joanna Schwartz, K. Wilson, Claire F. Verschraegen, Thomas H. Openshaw, J Valentine, J Eneman, P Ung...> ;Supportive Care in Cancer. 2016 Feb 19
53 citations
Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer.
Steven Ades, S. Kumar, M. W. Alam, A. Goodwin, D. Weckstein, M. Dugan, Takamaru Ashikaga, Mark Evans, Claire F. Verschraegen, Chris E. Holmes> ;Journal of Thrombosis and Haemostasis. 2015 Jun 1
Delayed human herpes virus 6 encephalitis in a patient with allogeneic stem cell transplant.
Jacqueline O’Toole, Steven Ades, Brenda L. Waters, Zubin Agarwal, Gurpreet Lamba> ;Leukemia & Lymphoma. 2015 Jan 28
18 citations
Survival and Recurrence Patterns after Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) for Locally Advanced Esophagogastric Adenocarcinoma
Monisha Sudarshan, Thierry Alcindor, Steven Ades, Abdullah Aloraini, Marie van Huyse, Jamil Asselah, Marc David, Dominique Frechette, Sonia Brisson, M. Thirlwell, Lore...> ;Annals of Surgical Oncology. 2015 Jan 1
Join now to see all

Journal Articles

Cost-Effectiveness of Prostate Radiation Therapy for Men with Newly Diagnosed Low-Burden Metastatic Prostate Cancer
Nataniel H Lester-Coll, Steven Ades, James B Yu, JAMA Network Open

Abstracts/Posters

Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis Prevention
Steven Ades, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Gastrointestinal (Noncolorectal) Cancer
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Press Mentions

How to Prevent a Cyberattack from Derailing Cancer CareOctober 1st, 2021
Non-Operative Management and Early Response Assessment in Rectal Cancer (NOM-ERA)December 8th, 2023

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

University of Vermont Medical CenterBurlington, Vermont